BIOCON PHARMA FDA Approval ANDA 214476

ANDA 214476

BIOCON PHARMA

FDA Drug Application

Application #214476

Application Sponsors

ANDA 214476BIOCON PHARMA

Marketing Status

Prescription001

Application Products

001TABLET, DELAYED RELEASE;ORAL100MG0POSACONAZOLEPOSACONAZOLE

FDA Submissions

UNKNOWN; ORIG1AP2022-02-04STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

BIOCON PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214476
            [companyName] => BIOCON PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"POSACONAZOLE","activeIngredients":"POSACONAZOLE","strength":"100MG","dosageForm":"TABLET, DELAYED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/04\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-02-04
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.